Ignite Creation Date:
2025-12-24 @ 12:01 PM
Ignite Modification Date:
2025-12-29 @ 4:26 PM
Study NCT ID:
NCT05851261
Status:
COMPLETED
Last Update Posted:
2024-04-16
First Post:
2023-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety, Tolerance, Pharmacokinetics Characteristics of PA3670 Tablets in Chinese Healthy Subjects
Sponsor:
Zhejiang Palo Alto Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-13
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2023-02-08
First Submit QC Date:
None
Study First Post Date:
2023-05-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-15
Last Update Post Date:
2024-04-16
Last Update Post Date Type:
ACTUAL